ReviewMedComm2026
Brown Adipose Tissue: Molecular Mechanisms of Regulation, Physiological Functions, and Therapeutic Targets.
Review in MedComm, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brown adipose tissue (BAT) biology has undergone a profound evolution over the past two decades, expanding from a narrow focus on thermogenic capacity in rodents to the establishment of its pleiotropic roles in human metabolic regulation. While this transition has enabled major progress in defining underlying molecular mechanisms and strengthened the clinical rationale for targeting BAT, it has also exposed unresolved challenges and knowledge gaps. In this review, we synthesize current evidence across the field, integrating findings from molecular, physiological, and translational studies to delineate the hierarchical regulatory networks that govern BAT development and function. We focus on three themes: first, the transcriptional, epigenetic, and posttranscriptional mechanisms that establish and maintain BAT identity; second, the expanding spectrum of BAT's physiological functions beyond thermogenesis, including its crosstalk with other metabolic organs and the immune system; and third, the emerging strategies and persistent obstacles in harnessing BAT's therapeutic potential for obesity, diabetes, and related metabolic disorders. By consolidating these perspectives, we propose an integrative framework for understanding BAT as a central hub in human metabolic regulation while identifying critical knowledge gaps that warrant further investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.